Transcatheter aortic valve implantation and the management of coronary artery disease
2018 ◽
pp. 600-606
Keyword(s):
The advent of transcatheter aortic valve implantation (TAVI) has provoked a paradigm shift in the treatment of senile calcific aortic stenosis (AS), the most common valvular disease in the developed world. Its benefits in high-risk and inoperable patients and its comparable outcomes to surgical aortic valve replacement are well established, and there is now evidence supporting use of the technique in intermediate-risk patients. AS often coexists with coronary artery disease (CAD) and, in seeking to further improve outcomes and minimize risks in the TAVI procedure, the management of concomitant CAD is an important consideration.
2020 ◽
Vol 125
(4)
◽
pp. 589-596
◽
2020 ◽
Vol 125
(8)
◽
pp. 1216-1221
◽
2013 ◽
Vol 61
(12)
◽
pp. 663-668
◽
2013 ◽
Vol 167
(3)
◽
pp. 943-950
◽
2018 ◽
Vol 10
(1)
◽
pp. E79-E82
◽
2017 ◽
Vol 91
(1)
◽
pp. 115-123
◽
2013 ◽
Vol 61
(10)
◽
pp. E1201
2017 ◽
Vol 243
◽
pp. 150-155
◽